We are live on
!
Find out more
3C
361 Capital Portfolio holdings
AUM
$213M
1-Year Est. Return
24.26%
This Fund
S&P 500
This Quarter
Est. Return
-20.52%
1 Year Est. Return
+24.26%
3 Year Est. Return
+117.64%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$220M
AUM Growth
-$141M
(-39%)
Cap. Flow
-$75.9M
Cap. Flow
% of AUM
-34.5%
Top 10 Holdings %
Top 10 Hldgs %
7.96%
Holding
421
New
120
Increased
25
Reduced
138
Closed
136
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Williams Companies
WMB
|
+$1.94M |
| 2 |
BERY
Berry Global Group, Inc.
BERY
|
+$1.81M |
| 3 |
TransUnion
TRU
|
+$1.79M |
| 4 |
RenaissanceRe
RNR
|
+$1.76M |
| 5 |
SBNY
Signature Bank
SBNY
|
+$1.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$2.21M |
| 2 |
PACCAR
PCAR
|
+$2.16M |
| 3 |
Spotify
SPOT
|
+$2.12M |
| 4 |
US Foods
USFD
|
+$2.06M |
| 5 |
ONE Gas
OGS
|
+$1.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.83% |
| 2 | Healthcare | 15.4% |
| 3 | Industrials | 12.81% |
| 4 | Financials | 12.39% |
| 5 | Real Estate | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
PRA Group
PRAA
$672M
| $706K | 0.32% |
+25,456
| New | +$887K |
|
152
Insight Enterprises
NSIT
$3.85B
| $705K | 0.32% |
+16,740
| New | +$969K |
|
153
SouthState Bank Corp
SSB
$10.3B
| $705K | 0.32% |
+11,998
| New | +$887K |
|
154
Motorola Solutions
MSI
$72.1B
| $704K | 0.32% |
5,295
+2,343
| +79% | +$393K |
|
155
Dorian LPG
LPG
$1.96B
| $703K | 0.32% |
80,722
-19,146
| -19% | -$226K |
|
156
Boise Cascade
BCC
$2.73B
| $701K | 0.32% |
+29,477
| New | +$1M |
|
157
Prestige Consumer Healthcare
PBH
$2.47B
| $701K | 0.32% |
19,110
-17,675
| -48% | -$686K |
|
|
SGMO
158
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $695K | 0.32% |
+109,161
| New | +$810K |
|
159
Primerica
PRI
$10.1B
| $691K | 0.31% |
+7,811
| New | +$893K |
|
160
Itron
ITRI
$4.48B
| $690K | 0.31% |
12,364
-7,641
| -38% | -$581K |
|
|
AMED
161
DELISTED
Amedisys
AMED
| $687K | 0.31% |
3,745
-6,107
| -62% | -$1.09M |
|
162
Huron Consulting
HURN
$2.71B
| $687K | 0.31% |
15,156
-3,593
| -19% | -$217K |
|
163
Repligen
RGEN
$6.91B
| $686K | 0.31% |
7,107
-6,928
| -49% | -$669K |
|
164
First American
FAF
$7.98B
| $684K | 0.31% |
16,123
-2,886
| -15% | -$165K |
|
165
Perdoceo Education
PRDO
$2.17B
| $683K | 0.31% |
63,261
-15,003
| -19% | -$233K |
|
166
Griffon
GFF
$4.02B
| $676K | 0.31% |
+53,441
| New | +$964K |
|
167
B&G Foods
BGS
$303M
| $675K | 0.31% |
+37,298
| New | +$584K |
|
168
SPX Corp
SPXC
$9.39B
| $673K | 0.31% |
+20,615
| New | +$929K |
|
169
Encore Capital Group
ECPG
$2.01B
| $664K | 0.3% |
28,395
-6,712
| -19% | -$226K |
|
170
Moog Inc Class A
MOG.A
$12.4B
| $664K | 0.3% |
+13,135
| New | +$1.02M |
|
171
CBIZ
CBZ
$2.98B
| $663K | 0.3% |
+31,707
| New | +$807K |
|
|
PPBI
172
DELISTED
Pacific Premier Bancorp
PPBI
| $661K | 0.3% |
+35,077
| New | +$934K |
|
173
CBRE Group
CBRE
$43.3B
| $660K | 0.3% |
17,496
-4,426
| -20% | -$245K |
|
174
United Therapeutics
UTHR
$26.1B
| $659K | 0.3% |
+6,947
| New | +$660K |
|
|
AEL
175
DELISTED
American Equity Investment Life Holding Company
AEL
| $657K | 0.3% |
34,970
-8,283
| -19% | -$211K |
|
Similar funds
SIA
PV
RCM
ALIA
TL
RI
SMFS
HF
361 Capital's Q1 2020 Portfolio in Review
As of Q1 2020, 361 Capital held 421 positions worth $220M, down 39% from $361M the previous quarter. Its ten largest holdings account for 8% of the portfolio.
361 Capital withdrew a net $75.9M in Q1 2020, closing 136 positions and reducing 138 holdings. Its most notable exit was Jazz Pharmaceuticals, an estimated $2.21M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 13% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, 361 Capital opened a new position in Williams Companies worth $1.42M.
- 361 Capital's largest Q1 2020 buy was Williams Companies: 100,317 shares worth $1.42M.
- 361 Capital added most to Huntington Ingalls Industries in Q1 2020, an estimated $1.2M increase.
- 361 Capital's biggest Q1 2020 reduction was Zebra Technologies, cutting an estimated $1.52M.
- 361 Capital fully exited Jazz Pharmaceuticals in Q1 2020, selling an estimated $2.21M.
- 361 Capital's ten largest holdings make up 8% of its $220M portfolio in Q1 2020.
- 361 Capital opened 120 new positions and closed 136 in Q1 2020.
- 361 Capital's portfolio value fell 39% quarter-over-quarter to $220M.
Based on 361 Capital's 13F filing for Q1 2020, filed 13 May 2020.